← Back to screener

USANA HEALTH SCIENCES INC USNA

Rank #19 · NYSE · $0.3B market cap
Audited by KPMG LLP, no going-concern flag in the latest filing.
Score
83.8
P/E
4.1
P/B
0.61
ROE
14.7%
Op. Margin
10.1%
Debt Ratio
37%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★★★★★
Excellent

P/E 4.1x, P/B 0.61x. Ranks in the top 4% of the universe.

Profitability ★★★☆☆
Good

ROE 14.7%. Ranks in the top 37% of the universe.

Safety ★★★★☆
Excellent

Debt ratio 37%. Ranks in the top 20% of the universe. Under 100% is generally considered a safe level.

Growth ★☆☆☆☆
Weak

Revenue decline of 7.8% year over year. Ranks in the top 80% of the universe.

Valuation is the relative strength · Growth is the relative weakness (relative to this universe).

Financials annual, from SEC 10-K filings

FYRevenueOp. IncomeNet IncomeEquityOp. Margin%Debt%
2011–$0.1B$0.0B$0.0B–580
2012–$0.1B$0.0B$0.1B–229
2013–$0.1B$0.1B$0.1B–82
2014–$0.1B$0.1B$0.2B–112
2015–$0.1B$0.1B$0.2B–89
2016–$0.1B$0.1B$0.3B–62
2017–$0.1B$0.1B$0.2B–104
2018$1.0B$0.1B$0.1B$0.3B13.885
2019$1.0B$0.1B$0.1B$0.3B12.770
2020$1.2B$0.2B$0.1B$0.4B15.842
2022$1.1B$0.2B$0.1B$0.4B15.664
2023$1.0B$0.1B$0.1B$0.4B10.834
2025$0.9B$0.1B$0.1B$0.4B10.137

← See the full screener